NCT04119505

Brief Summary

Acute respiratory failure is one of the most common diagnosis in patients admitted in the Emergency Department. Acute respiratory failure is associated with morbidity and mortality. Fifteen percent of patient will require ventilatory support and among them 40% will die. Measurement of diaphragmatic motion (excursion) at ultrasonography is a noninvasive measure, allowing to assess diaphragm dysfunction. It could be useful in predicting poor prognosis in ED patients with respiratory failure . In this study the investigators will compare the prognostic value of diaphragmatic excursion measurement at ultrasonography to that of the National Early Warning Score (NEWS) 2 in patients presenting with acute respiratory failure in the ED The Investigators made the hypothesis that measurement of diaphragmatic excursion in ED patients with acute respiratory failure could be of value in predicting the need for ventilatory support or mortality within 28 days from ED admission

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
24 days until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2020

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

1 year

First QC Date

September 25, 2019

Last Update Submit

December 28, 2020

Conditions

Keywords

Diaphragmatic ExcursionDiaphragmatic DysfunctionEmergency DepartmentRespiratory insufficiencyAcute respiratory failure

Outcome Measures

Primary Outcomes (1)

  • Number of patients with adverse events

    Adverse events are defined as a composite of mortality and/or cardiac arrest and/or need for ventilatory support (including invasive and/or noninvasive ventilation and/or high flow nasal cannula therapy) within 28 days from ED admission.

    28 days

Secondary Outcomes (3)

  • Delay to initiation of ventilatory support

    at day 28

  • Number of patients with adverse events at ED discharge

    through ED stay (up to a day)

  • Number of patients with adverse events at hospital discharge

    through hospital stay (up to a week)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted in the Emergency Department for Acute Respiratory Failure

You may qualify if:

  • Age equal or over 18 y.o
  • Signs of acute respiratory failure defined by RR equal or over 25 br/min and/or signs of increased work of breathing
  • Patients on spontaneous breathing

You may not qualify if:

  • Medical history of diaphragmatic dysfunction including stroke or diaphragmatic paralysis
  • Patients treated with curare
  • Trauma patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

DyspneaEmergenciesRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Study Officials

  • Nicolas MARJANOVIC, MD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2019

First Posted

October 8, 2019

Study Start

November 1, 2019

Primary Completion

November 1, 2020

Study Completion

December 28, 2020

Last Updated

December 29, 2020

Record last verified: 2020-12

Locations